Novartis Keeps FY 2026 Net Sales Growth At Low Single-Digit, Raises Core Operating Income Outlook To In Line To Low Single-Digit Growth

Full-year 2026 guidance raised for core operating income o Net sales expected to grow low single-digit (unchanged) o Core operating income expected to be in line to grow low single-digit (from decline low single-digit)